IP Library Granted Patent US 9,649,479
Granted Patent B2
US 9,649,479 · App. 15/078,940 · Granted May 16, 2017

Balloon catheter systems for delivery of dry drug delivery vesicles to a vessel in the body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,479
App. No.
15/078,940
Granted
May 16, 2017
Kind
B2
Abstract

Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.

Claims (19)

1. A method of treating a lesion in a blood vessel of a patient comprising the steps of:

providing a balloon catheter system comprising:

a catheter body characterized by a distal portion and a proximal portion;

a first balloon disposed on the distal portion of the catheter body, said first balloon having a porous wall portion, said porous wall portion having pores with a diameter of about 0.1 to 5 microns;

providing a reservoir of lyophilized micelles with rapamycin encapsulated in the micelles;

providing a reservoir of aqueous solution suitable for mobilizing the micelles within the micelle reservoir;

mixing the aqueous solution with the micelles to wet and mobilize the micelles, such that the micelles have a particle size of 40 to 250 nm; and

delivering the micelles to the lesion, through the porous wall portion of the first balloon, by injecting the micelles into the first balloon and pressurizing the first balloon to a pressure of 6 to 12 atmospheres to force the micelles through the porous wall portion of the first balloon into the blood vessel.

2. The method of claim 1 further comprising the steps of:

providing the balloon catheter system with a second balloon disposed on the distal portion of the catheter body, within the first balloon, defining an inter-balloon space between the first balloon and the second balloon; and

accomplishing the step of pressurizing the first balloon by inflating the second balloon.

3. The method of claim 2 further comprising the step of:

pressurizing the first balloon to perform angioplasty within the blood vessel.

4. The method of claim 2 further comprising the steps of:

pressurizing the first balloon to perform angioplasty within the blood vessel, and thereafter inflating the second balloon to pressurize the first balloon and thereby force the micelles through the porous wall portion of the first balloon.

5. The method of claim 4 , wherein the step of inflating the second balloon to pressurize the first balloon and thereby force the micelles through the porous wall portion of the first balloon is accomplished while the first balloon is filled with the aqueous solution with the micelles.

6. The method of claim 4 , wherein the step of pressurizing the first balloon to perform angioplasty is accomplished to perform angioplasty at a target site within the blood vessel, and the step of inflating the second balloon to pressurize the first balloon and thereby force the micelles through the porous wall portion of the first balloon is accomplished to force the micelles through the porous wall portion of the first balloon at the target site within the blood vessel.

7. The method of claim 1 further comprising the step of:

pressurizing the first balloon to perform angioplasty within the blood vessel.

Assignments (7)
SECURITY INTEREST Recorded Aug 7, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: MEDTRONIC, INC.
Reel/Frame 072341/0075 →
SECURITY INTEREST Recorded Aug 4, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 072359/0219 →
SECURITY INTEREST Recorded Nov 6, 2024
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC
To: HERCULES CAPITAL, INC.
Reel/Frame 069312/0758 →
RELEASE OF IP SECURITY INTEREST Recorded Oct 9, 2023
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
Reel/Frame 065192/0001 →
SECURITY AGREEMENT Recorded Jun 6, 2022
From: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 060286/0021 →
ENTITY CONVERSION Recorded Feb 12, 2020
From: CALIBER THERAPEUTICS, INC.
To: CALIBER THERAPEUTICS, LLC
Reel/Frame 051911/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2016
From: BAUMBACH, WILLIAM R.; SHERMAN, DARREN R.; BURGERMEISTER, ROBERT S.
To: CALIBER THERAPEUTICS, INC.
Reel/Frame 038090/0494 →